Charles M. Baum - Jun 22, 2023 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Jun 22, 2023
Transactions value $
$0
Form type
3
Date filed
6/28/2023, 04:58 PM
Previous filing
Jun 16, 2023
Next filing
Aug 10, 2023

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney